Skip to main content
CDC Website

At Risk Persons

Pre-Exposure Prophylaxis (PrEP): A Potential New Method for HIV Prevention

This pamphlet discusses pre-exposure prophylaxis (PrEP), a medical term for giving medicines that fight HIV to people who are not infected before they are in contact with the virus, to try and prevent infection. The pamphlet explains that this approach is being studied in clinical trials with injection drug users in Asia; men who have sex with men in the United States, Africa, Asia, and Latin America; and heterosexual men and women in Africa. Results of the trials will be available in late 2009 and 2010.

Viral Hepatitis: Information for Gay and Bisexual Men

This information sheet discusses the viral infections Hepatitis A, Hepatitis B, and Hepatitis C, which cause liver disease. It describes the modes of transmission for each, the epidemiology of these diseases in the United States, the difference between acute and chronic disease as well as the symptoms, methods of diagnosis, and treatment. The information sheet explains the high risk of these diseases among gay and bisexual men and notes that experts recommend that gay and bisexual men should be tested for Hepatitis B and should be vaccinated for Hepatitis A and B.

Hepatitis C: General Information

This information sheet provides general information about hepatitis C. It explains that hepatitis is an inflammation of the liver, and hepatitis C is a contagious liver disease caused by a virus. The information sheet discusses the effect of hepatitis C on the liver, the acute and chronic forms of the disease, hepatitis C transmission, its epidemiology, the seriousness of the disease, its symptoms, diagnostic tests that are used, who should be tested, the treatment, and how people with hepatitis C can take care of their liver.

Hepatitis B: Informacion General

This information sheet provides general information about hepatitis B. It explains the disease; provides statistics on hepatitis B in the United States; and discusses at-risk persons, transmission, symptoms, diagnosis, and treatment of Hepatitis B. It promotes vaccine as the best method of preventing the disease and lists persons who should get vaccinated against hepatitis B.

HIV Testing in the US

This information sheet provides data on HIV testing in the United States. It states that not enough people know their HIV status by getting tested. It discusses who has been tested and breaks down statistics by race, sex, age, and state. It also gives information on how to locate a testing location.

TB Elimination: Tuberculin Skin Testing

This information sheet discusses TB testing using the Mantoux tuberculin skin test (TST) to determine whether an individual is infected with Mycobacterium TB. It discusses how the TST is administered, how it is read, how TST reactions are interpreted the classification of the TST skin test reaction, what are false-positive and false-negative reactions, who can receive a TST and how often the test can be repeated, what is a boosted reaction, why two-step testing is conducted, and whether TSTs can be given to persons receiving vaccinations.

TB Elimination: Targeted Tuberculosis Testing and Interpreting Tuberculin Skin Test Results

The information sheet discusses targeted TB testing, the decision to focus on groups at highest risk for latent TB infection (LTBI) and advises appropriate treatment and treatment completion to prevent LTBI progressing to active disease. It explains tuberculin skin testing (TST) and the test reactions that indicate whether an individual has LTBI; lists the criteria for classifying positive TST reactions; and describes persons at risk for developing TB disease including clinical conditions that increase the risk of LTBI becoming TB disease.